Thursday, August 17, 2023

Pilot plant scale up consideration II

 Pilot Plant Scale-Up Techniques 

Pilot plant scale up consideration for solid dosage form

Pilot plant scale up consideration II


        Consideration of Processing equipment

       Dispensing booth

       Qualified and calibrated equipments

       Capacity of equipments

       Sieving machine

       RMG

       FBD

       Milling

       Blender

       Compression machine

       Coating Machine

       Packing Machine

        Consideration of Granulation process

       Processing environment

       Milling before sieving

       Sieving of raw materials

       Dry or wet granulation

       RMG speeds and timing of granulation

       Paste addition and its quantity for wet granulation

       Determination of drug content after dry and wet granulation

        Consideration of Drying process

       Processing environment

       Milling before drying if required

       Drying Temperature

       Drying time

       Determination of LOD (loss on drying)

       Determination of drug content after drying

        Consideration of Milling process

       Granule size requirement

       Milling after drying for desire size

       Screen selection

       Requirement of fines quantity

       Storage of milled granules before lubrication

       To perform sieve analysis to know granule sizes

        Consideration of Blending process

       Environmental requirement

       Selection of blender

       Blending time

       Blending speed

       Addition of lubricant

       Blending time after addition of lubricant

       Determination of uniformity of content

       Determination of angle of repose

        Consideration of Compression process

       Environmental requirement

       Selection of compression machine

       Selection of Punches

       Identification of problems and its trouble shouting

       Compression speed optimization

       IPQC testing at various challenges for compression operation

       Quality control testing and determination of content

        Consideration of Coating process

       Environmental requirement

       Selection of coating machine

       Speed of pan

       Coating material spraying rate

       Pan bed temperature

       Coating time

       Weight gain due to coating material

       Drying of coated tablets

       IPQC testing at various challenges for coating operation

       Quality control testing and determination of content

        Consideration of Packing process

       Environmental requirement

       Selection of packing machine

       Packing material

       Cavity forming temperature

       Sealing temperature

       Machine speed

       Performing leak test for sealing confirmation

       Verification of printing details

Pilot plant scale up consideration for solid dosage form


Scaling up pharmaceutical solid dosage forms, such as tablets and capsules, from laboratory to pilot plant involves specific considerations to ensure product quality, consistency, and regulatory compliance. Here are key factors to take into account during the scale-up process:

1. Formulation Compatibility:

·   Verify that the formulation can be successfully reproduced at a larger scale without changes that could affect product quality.

·     Ensure that excipient interactions, particle size distribution, and other formulation parameters remain consistent.

2. Raw Material Sourcing:

·    Ensure a stable supply chain for raw materials, excipients, and active pharmaceutical ingredients (APIs) required for larger-scale production.

·       Evaluate any potential changes in material quality or properties when moving to larger quantities.

3. Equipment Selection and Validation:

·      Choose equipment that can handle larger batch sizes while maintaining uniform mixing, granulation, compression, and other unit operations.

·       Validate the performance of equipment for the intended scale to ensure consistent results.

4. Process Optimization:

·   Optimize process parameters, such as mixing speed, granulation time, compression force, and drying conditions, for the larger equipment.

·       Assess the impact of scale on critical process variables and adjust as needed.

5. Blend Uniformity and Content Uniformity:

·       Ensure that blends and final dosage forms maintain uniform distribution of API and excipients.

·       Validate blending and content uniformity methods to confirm compliance with specifications.

6. Compression and Tableting:

·       Adjust compression force and dwell time to achieve tablets with the desired hardness, friability, and disintegration time.

·       Monitor tablet weight variation and ensure consistent tablet quality.

7. Coating (if applicable):

·    If coating is involved, adjust coating parameters (e.g., spray rate, inlet/outlet air temperatures) for larger coating pans.

·       Validate the coating process to ensure uniform and reproducible coating quality.

8. Quality Control and Testing:

·    Develop and validate analytical methods to ensure accurate and reliable testing of raw materials, intermediates, and finished products.

·       Establish specifications for physical attributes, dissolution rates, and other quality attributes.

9. In-Process Controls:

·       Implement in-process controls to monitor critical process parameters and maintain product quality during manufacturing.

·     Use techniques such as process analytical technology (PAT) to monitor and control the process in real-time.

10. Regulatory Compliance:

·      Ensure that the scaled-up process adheres to regulatory requirements and guidelines, including Good Manufacturing Practices (GMP).

·       Update documentation, such as batch records and standard operating procedures (SOPs), to reflect the new scale.

11. Process Validation:

·     Plan and execute process validation studies to demonstrate that the scaled-up process consistently produces dosage forms meeting quality specifications.

·       Validate critical process parameters, equipment performance, and cleaning procedures.

12. Packaging and Labeling:

·       Adjust packaging and labeling processes to accommodate larger quantities of products.

·       Ensure that packaging materials are suitable for the larger batch size and maintain product integrity.

13. Environmental and Safety Considerations:

·   Evaluate safety risks associated with handling larger quantities of materials and operating larger equipment.

·       Implement safety measures to protect personnel and the environment.

14. Documentation and Reporting:

·       Document all steps, deviations, and adjustments made during scale-up trials.

·       Compile detailed reports to facilitate knowledge transfer and decision-making.

15. Continuous Monitoring and Improvement:

·   Continuously monitor the scaled-up process, collect data, and analyze results to identify opportunities for optimization and improvement.

Scaling up pharmaceutical solid dosage forms requires careful planning, collaboration among various departments, and adherence to regulatory standards. By considering these factors and systematically addressing potential challenges, you can ensure a successful and efficient scale-up process.

No comments:

Post a Comment